US state passes law allowing experimental drugs to be prescribed – a model for the future?

Cancer survivors who received high-cost immunotherapies appear more likely to experience financial hardship, according to study results published in Journal of Cancer Survivorship.

Human health is complex and diagnostic tools and their limitations, so missing a diagnosis is sometimes unavoidable.

Are patients being prescribed more medications not for their health, but to generate profit?

Congressman Greg Murphy, M.D., alongside Congressmen Adam Gray (D-CA) and Neal Dunn (R-FL), introduced the Protecting Patient Access to Cancer and Complex Therapies Act, legislation to revert physician reimbursement for administering drugs under Medicare Part B to Average Sales Price (ASP) plus 6 percent, create an additional rebate paid by manufacturers, and hold patients harmless by basing coinsurance rates off the Maximum Fair Price (MFP).